Abbott Laboratories (ABT) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Abbott Laboratories's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
33.50
Weak
WeakModerateStrong
P/B Ratio
4.20
Strong
WeakModerateStrong
Earnings Yield
2.98%
Yield Trap
WeakModerateStrong
Profitability Health
2025Return on Equity
12.51%
Moderate
WeakModerateStrong
Operating Margin
18.16%
Moderate
WeakModerateStrong
Net Profit Margin
14.72%
Moderate
WeakModerateStrong
Growth Indicators
2025Revenue Growth
5.67%
Moderate
WeakModerateStrong
Net Income Growth
-51.32%
Weak
WeakModerateStrong
EPS Growth
-51.24%
Weak
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
1.58
Moderate
WeakModerateStrong
Quick Ratio
1.18
Moderate
WeakModerateStrong
Asset Turnover
0.51x
Moderate
WeakModerateStrong
Inventory Turnover
3.04x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
3.38%
Moderate
WeakModerateStrong
EV / Free Cash Flow
30.48x
Moderate
WeakModerateStrong
Net Debt / EBITDA
0.57x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.052
Strong
WeakModerateStrong
Return on Invested Capital
8.43%
Weak
WeakModerateStrong
Cash Conversion Cycle
106.89 days
Weak
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for ABT.
View Financial Statements